Cramer calls this drug maker the 'greatest growth stock.' He also names a runner-up

Market Overview - Stocks rebounded on Friday, with the Dow surging more than 950 points or nearly 2%, indicating a strong market recovery [1] - The S&P 500 and Nasdaq each rallied about 1.5% on Friday, although both indexes remained in the red for the week due to a recent rotation out of tech stocks [1] Company Performance - Eli Lilly shares increased by 3% on Friday after an almost 8% decline in the previous session, attributed to broader market sell-off and competition from Hims & Hers launching a compounded version of Novo Nordisk's Wegovy [1] - The FDA's announcement to take action against illegal copycat drugs contributed to the bounce in Eli Lilly's stock, with the company being highlighted as a significant growth stock [1] - Linde's shares dropped another 1.7% following a 2.9% decline on Thursday, after JPMorgan downgraded the industrial gas giant to a hold-equivalent rating [1] - Despite the downgrade, Linde's price target was raised from $500 to $510, indicating continued confidence in the company's long-term prospects [1] Notable Stocks - Club holdings and Dow components such as Nvidia, Cisco, Boeing, Honeywell, Procter & Gamble, and Nike all experienced gains, while Amazon saw a decline of 7.5% after its earnings report revealed significant spending plans and lighter than expected guidance [1]